Related references
Note: Only part of the references are listed.Chip-based human liver-intestine and liver-skin co-cultures - A first step toward systemic repeated dose substance testing in vitro
Ilka Maschmeyer et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
A multi-organ chip co-culture of neuro spheres and liver equivalents for long-term substance testing
Eva-Maria Materne et al.
JOURNAL OF BIOTECHNOLOGY (2015)
A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents
Ilka Maschmeyer et al.
LAB ON A CHIP (2015)
Current status of pluripotent stem cells: moving the first therapies to the clinic
Erin A. Kimbrel et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Organs-on-chips at the frontiers of drug discovery
Eric W. Esch et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes
Brenton R. Ware et al.
TOXICOLOGICAL SCIENCES (2015)
A novel low-volume two-chamber microfabricated platform for evaluating drug metabolism and toxicity
Shyam Sundhar Bale et al.
TECHNOLOGY (2015)
Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity
Dan Xu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Fialuridine Induces Acute Liver Failure in Chimeric TK-NOG Mice: A Model for Detecting Hepatic Drug Toxicity Prior to Human Testing
Dan Xu et al.
PLOS MEDICINE (2014)
Rapid induction of colon carcinogenesis in CYP1A-humanized mice by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate
Connie Cheung et al.
CARCINOGENESIS (2011)
Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models
Xi-Ling Jiang et al.
DRUG METABOLISM REVIEWS (2011)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The CYP2E1-humanized transgenic mouse:: Role of CYP2E1 in acetaminophen hepatotoxicity
C Cheung et al.
DRUG METABOLISM AND DISPOSITION (2005)
Making better drugs: Decision gates in non-clinical drug development
JF Pritchard et al.
NATURE REVIEWS DRUG DISCOVERY (2003)